These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9170607)
1. [Toxicokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice and rats during 13-week dietary administration]. Nakazawa M; Kitayama E; Adachi T; Yoshida M; Ishibashi S; Yoshikawa K; Kajihara T; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():177-85. PubMed ID: 9170607 [TBL] [Abstract][Full Text] [Related]
2. [Oral single-dose and 13-week repeat-dose toxicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in rats]. Furukawa S; Kouyama H; Kikumori M; Taniguchi Y; Nishimori T; Ishibashi S; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():93-124. PubMed ID: 9170604 [TBL] [Abstract][Full Text] [Related]
3. Two-year dietary carcinogenicity study of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats. Hatch RC; Regan KS; Ishibashi S; Nakazawa M; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():289-306. PubMed ID: 9170616 [TBL] [Abstract][Full Text] [Related]
4. Seventy-eight-week dietary carcinogenicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice. Hatch RC; Regan KS; Ishibashi S; Nakazawa M; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():275-87. PubMed ID: 9170615 [TBL] [Abstract][Full Text] [Related]
5. [A 26-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 9-week recovery test]. Okasaki K; Baba S; Ikeda H; Chihaya Y; Satake S; Nagata R; Ishibashi S; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():59-92. PubMed ID: 9170603 [TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal single-dose toxicity studies of active metabolite, optical isomers, hydrolysis products and bi-product of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice]. Nishimura N; Kobayashi J; Moro M; Katsumata T; Nishiguchi Y; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():15-25. PubMed ID: 9170601 [TBL] [Abstract][Full Text] [Related]
7. [Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence]. Tamura H; Yamashita Y; Kitayama E; Iwakura K; Watanabe M; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():263-74. PubMed ID: 9170614 [TBL] [Abstract][Full Text] [Related]
8. [A 13-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 5-week recovery test]. Nishiguchi Y; Adachi T; Nakazawa M; Tawaratani T; Uchimoto H; Yoshida M; Ishibashi S; Kitayama E; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():27-57. PubMed ID: 9170602 [TBL] [Abstract][Full Text] [Related]
9. [A 12-month oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in dogs followed by a 2-month recovery test]. Yoshida M; Kawaminami A; Tawaratani T; Ishibashi S; Nakazawa M; Kitayama E; Oka T; Adachi T; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():147-75. PubMed ID: 9170606 [TBL] [Abstract][Full Text] [Related]
10. [Single-dose toxicity studies of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice, rats and dogs]. Nishiguchi Y; Yoshida M; Tarui M; Nakazawa M; Oka T; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():1-13. PubMed ID: 9170600 [TBL] [Abstract][Full Text] [Related]
11. [Reproductive and developmental toxicity studies of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence (2). Teratogenicity study in rats by oral administration]. Schardein JL; York RG; Ninomiya H; Watanabe M; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():213-28. PubMed ID: 9170610 [TBL] [Abstract][Full Text] [Related]
12. [Antigenicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence]. Okasaki K; Nagata R; Ohnishi M; Samejima H; Fujisawa H; Kimura K J Toxicol Sci; 1997 Apr; 22 Suppl 1():307-13. PubMed ID: 9170617 [TBL] [Abstract][Full Text] [Related]
13. [A 13-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in dogs followed by a 5-week recovery test]. Yoshida M; Oka T; Tawaratani T; Ishibashi S; Nakazawa M; Kitayama E; Adachi T; Iwakura K; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():125-46. PubMed ID: 9170605 [TBL] [Abstract][Full Text] [Related]
14. [Reproductive and developmental toxicity studies of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence (1). Fertility study in rats by oral administration]. Schardein JL; York RG; Ninomiya H; Watanabe M; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():201-12. PubMed ID: 9170609 [TBL] [Abstract][Full Text] [Related]
15. [Reproductive and developmental toxicity studies of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence (3). Teratogenicity study in rabbits by oral administration]. Schardein JL; York RG; Ninomiya H; Watanabe M; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():229-37. PubMed ID: 9170611 [TBL] [Abstract][Full Text] [Related]
16. [Reproductive and developmental toxicity studies of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence (4). Perinatal and postnatal study in rats by oral administration]. Schardein JL; York RG; Ninomiya H; Watanabe M; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():239-49. PubMed ID: 9170612 [TBL] [Abstract][Full Text] [Related]
17. [Mutagenicity studies of (+/-)-4-diethylamino-1,1,-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence]. Otsuka M; Kajiwara Y; Ajimi S; Shimazaki H; Kikuno T; Ogura S; Inai T; Kakimoto K; Tamura H; Watanabe M; Sumi N J Toxicol Sci; 1997 Apr; 22 Suppl 1():251-61. PubMed ID: 9170613 [TBL] [Abstract][Full Text] [Related]
18. [The mechanism of increased thyroidal function caused by (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, administration in rats]. Ishibashi S; Nakazawa M; Tawaratani T; Yoshida M; Tamura H; Adachi T; Kawaguchi K; Iwakura K; Sumi N; Wakabayashi K J Toxicol Sci; 1997 Apr; 22 Suppl 1():187-99. PubMed ID: 9170608 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys. Nakamura A; Hirota T; Sugihara K; Morino A Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236 [TBL] [Abstract][Full Text] [Related]
20. Effect of the anticholinergic drug with calcium antagonistic activity, (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate, on lower urinary tract function in decerebrated dogs. Kimura Y; Fukui H; Hamada K; Ogasawara T; Yamazaki C; Ukai Y; Yoshikuni Y; Kimura K Arzneimittelforschung; 1997 Feb; 47(2):182-9. PubMed ID: 9079238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]